Literature DB >> 6417224

The sterilizing capacity of propylene oxide and chlorhexidine diacetate solutions upon pre-injection swabs saturated with propan-2-ol.

R C Wright.   

Abstract

The sporicidal activity of two solutions which have been used in the production of 'sterile' pre-injection swabs has been investigated. Propylene oxide (3.4% w/w) and chlorhexidine diacetate (0.6% w/w), both made up in approximately 65% w/w propan-2-ol, were artificially contaminated with spores of Bacillus subtilis var. niger and swabs were impregnated with these; surviving spores were enumerated at various temperatures and times of storage. Chlorhexidine diacetate had no sporicidal activity, whereas the activity of propylene oxide was dependent on temperature. The former should not be considered a sterilant and the latter can only be considered such if a controlled incubation period at an elevated temperature is employed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417224      PMCID: PMC2129380          DOI: 10.1017/s0022172400060307

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  4 in total

1.  A bacterial spore test piece for the control of ethylene oxide sterilization.

Authors:  M M Beeby; C E Whitehouse
Journal:  J Appl Bacteriol       Date:  1965-12

2.  Effect of temperature on the sterilization of isopropyl alcohol by liquid propylene oxide.

Authors:  A Hart; S N Ng
Journal:  Appl Microbiol       Date:  1975-09

3.  Effect of propylene oxide treatment on the microflora of pecans.

Authors:  R O Blanchard; R T Hanlin
Journal:  Appl Microbiol       Date:  1973-11

4.  Propylene oxide as sterilizing agent.

Authors:  A Hart; M W Brown
Journal:  Appl Microbiol       Date:  1974-12
  4 in total
  1 in total

1.  Mycobacterium fortuitum endocarditis associated with cardiac surgery, Serbia.

Authors:  Dragana Vuković; Vojislav Parezanović; Branislava Savić; Ivana Dakić; Suzana Laban-Nestorović; Slobodan Ilić; Ivana Ćirković; Srdjan Stepanović
Journal:  Emerg Infect Dis       Date:  2013-03       Impact factor: 6.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.